Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1999 Aug;67(2):195–198. doi: 10.1136/jnnp.67.2.195

Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism

N Wakamatsu 1, M Hayashi 1, H Kawai 1, H Kondo 1, Y Gotoda 1, Y Nishida 1, R Kondo 1, S Tsuji 1, T Matsumoto 1
PMCID: PMC1736478  PMID: 10406988

Abstract

OBJECTIVES—Mutational analysis of the sterol 27-hydroxylase (CYP27) gene was performed on three patients from two Japanese families who had cerebrotendinous xanthomatosis (CTX) associated with parkinsonism.
METHODS—Clinical evaluations, brain MRI studies, and laboratory analyses were completed on the three patients. The CYP27 gene was analysed for mutations by PCR amplification of gene segments followed by direct sequencing.
RESULTS—Two different, homozygous mutations were identified in these families. One is a novel transition, substituting T for G at Glu162 (GAG) resulting in a stop codon (TAG). The other is also a transition, substituting T for C at Arg441 (CGG) resulting in Trp (TGG). The second is located in two amino acids ahead of the heme ligand binding site (Cys443) of the protein likely rendering it non-functional. It is the most common CTX mutation in Japanese patients.
CONCLUSIONS—CTX with parkinsonism is caused by mutations with a severe impact on enzyme function. The two mutations described here are likely to cause loss of function because they are chain terminating or affect an essential site in the protein.



Full Text

The Full Text of this article is available as a PDF (111.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed M. S., Afsar S., Hentati A., Ahmad A., Pasha J., Juneja T., Hung W. Y., Ahmad A., Choudhri A., Saya S. A novel mutation in the sterol 27-hydroxylase gene of a Pakistani family with autosomal recessive cerebrotendinous xanthomatosis. Neurology. 1997 Jan;48(1):258–260. doi: 10.1212/wnl.48.1.258. [DOI] [PubMed] [Google Scholar]
  2. Berginer V. M., Salen G., Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med. 1984 Dec 27;311(26):1649–1652. doi: 10.1056/NEJM198412273112601. [DOI] [PubMed] [Google Scholar]
  3. Cali J. J., Hsieh C. L., Francke U., Russell D. W. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem. 1991 Apr 25;266(12):7779–7783. [PMC free article] [PubMed] [Google Scholar]
  4. Cali J. J., Russell D. W. Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J Biol Chem. 1991 Apr 25;266(12):7774–7778. [PubMed] [Google Scholar]
  5. Chen W., Kubota S., Kim K. S., Cheng J., Kuriyama M., Eggertsen G., Björkhem I., Seyama Y. Novel homozygous and compound heterozygous mutations of sterol 27-hydroxylase gene (CYP27) cause cerebrotendinous xanthomatosis in three Japanese patients from two unrelated families. J Lipid Res. 1997 May;38(5):870–879. [PubMed] [Google Scholar]
  6. Chen W., Kubota S., Nishimura Y., Nozaki S., Yamashita S., Nakagawa T., Kameda-Takemura K., Menju M., Matsuzawa Y., Björkhem I. Genetic analysis of a Japanese cerebrotendinous xanthomatosis family: identification of a novel mutation in the adrenodoxin binding region of the CYP 27 gene. Biochim Biophys Acta. 1996 Nov 15;1317(2):119–126. doi: 10.1016/s0925-4439(96)00043-9. [DOI] [PubMed] [Google Scholar]
  7. Chen W., Kubota S., Seyama Y. Alternative pre-mRNA splicing of the sterol 27-hydroxylase gene (CYP 27) caused by a G to A mutation at the last nucleotide of exon 6 in a patient with cerebrotendinous xanthomatosis (CTX). J Lipid Res. 1998 Mar;39(3):509–517. [PubMed] [Google Scholar]
  8. Chen W., Kubota S., Teramoto T., Nishimura Y., Yonemoto K., Seyama Y. Silent nucleotide substitution in the sterol 27-hydroxylase gene (CYP 27) leads to alternative pre-mRNA splicing by activating a cryptic 5' splice site at the mutant codon in cerebrotendinous xanthomatosis patients. Biochemistry. 1998 Mar 31;37(13):4420–4428. doi: 10.1021/bi972940a. [DOI] [PubMed] [Google Scholar]
  9. Fiorelli M., Di Piero V., Bastianello S., Bozzao L., Federico A. Cerebrotendinous xanthomatosis: clinical and MRI study (a case report). J Neurol Neurosurg Psychiatry. 1990 Jan;53(1):76–78. doi: 10.1136/jnnp.53.1.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fujiyama J., Kuriyama M., Yoshidome H., Suehara M., Eiraku N., Kashio N., Osame M. Parkinsonism in cerebrotendinous xanthomatosis. Jpn J Med. 1991 Mar-Apr;30(2):189–192. doi: 10.2169/internalmedicine1962.30.189. [DOI] [PubMed] [Google Scholar]
  11. Garuti R., Lelli N., Barozzini M., Tiozzo R., Dotti M. T., Federico A., Ottomano A. M., Croce A., Bertolini S., Calandra S. Cerebrotendinous xanthomatosis caused by two new mutations of the sterol-27-hydroxylase gene that disrupt mRNA splicing. J Lipid Res. 1996 Jul;37(7):1459–1467. [PubMed] [Google Scholar]
  12. Kim K. S., Kubota S., Kuriyama M., Fujiyama J., Björkhem I., Eggertsen G., Seyama Y. Identification of new mutations in sterol 27-hydroxylase gene in Japanese patients with cerebrotendinous xanthomatosis (CTX). J Lipid Res. 1994 Jun;35(6):1031–1039. [PubMed] [Google Scholar]
  13. Kuriyama M., Fujiyama J., Yoshidome H., Takenaga S., Matsumuro K., Kasama T., Fukuda K., Kuramoto T., Hoshita T., Seyama Y. Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature. J Neurol Sci. 1991 Apr;102(2):225–232. doi: 10.1016/0022-510x(91)90073-g. [DOI] [PubMed] [Google Scholar]
  14. Leitersdorf E., Reshef A., Meiner V., Levitzki R., Schwartz S. P., Dann E. J., Berkman N., Cali J. J., Klapholz L., Berginer V. M. Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin. J Clin Invest. 1993 Jun;91(6):2488–2496. doi: 10.1172/JCI116484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Leitersdorf E., Safadi R., Meiner V., Reshef A., Björkhem I., Friedlander Y., Morkos S., Berginer V. M. Cerebrotendinous xanthomatosis in the Israeli Druze: molecular genetics and phenotypic characteristics. Am J Hum Genet. 1994 Nov;55(5):907–915. [PMC free article] [PubMed] [Google Scholar]
  16. Meiner V., Marais D. A., Reshef A., Björkhem I., Leitersdorf E. Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in an Afrikaner family. Hum Mol Genet. 1994 Jan;3(1):193–194. doi: 10.1093/hmg/3.1.193. [DOI] [PubMed] [Google Scholar]
  17. Mondelli M., Rossi A., Scarpini C., Dotti M. T., Federico A. Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid. Arch Neurol. 1992 May;49(5):469–475. doi: 10.1001/archneur.1992.00530290051011. [DOI] [PubMed] [Google Scholar]
  18. Nagai Y., Hirano M., Mori T., Takakura Y., Tamai S., Ueno S. Japanese triplets with cerebrotendinous xanthomatosis are homozygous for a mutant gene coding for the sterol 27-hydroxylase (Arg441Trp). Neurology. 1996 Feb;46(2):571–574. doi: 10.1212/wnl.46.2.571. [DOI] [PubMed] [Google Scholar]
  19. Nakamura T., Matsuzawa Y., Takemura K., Kubo M., Miki H., Tarui S. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. Metabolism. 1991 Jul;40(7):741–746. doi: 10.1016/0026-0495(91)90094-d. [DOI] [PubMed] [Google Scholar]
  20. Nakashima N., Sakai Y., Sakai H., Yanase T., Haji M., Umeda F., Koga S., Hoshita T., Nawata H. A point mutation in the bile acid biosynthetic enzyme sterol 27-hydroxylase in a family with cerebrotendinous xanthomatosis. J Lipid Res. 1994 Apr;35(4):663–668. [PubMed] [Google Scholar]
  21. Okuyama E., Tomita S., Takeuchi H., Ichikawa Y. A novel mutation in the cytochrome P450(27) (CYP27) gene caused cerebrotendinous xanthomatosis in a Japanese family. J Lipid Res. 1996 Mar;37(3):631–639. [PubMed] [Google Scholar]
  22. Reshef A., Meiner V., Berginer V. M., Leitersdorf E. Molecular genetics of cerebrotendinous xanthomatosis in Jews of north African origin. J Lipid Res. 1994 Mar;35(3):478–483. [PubMed] [Google Scholar]
  23. Segev H., Reshef A., Clavey V., Delbart C., Routier G., Leitersdorf E. Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in a French family. Hum Genet. 1995 Feb;95(2):238–240. doi: 10.1007/BF00209413. [DOI] [PubMed] [Google Scholar]
  24. Verrips A., Steenbergen-Spanjers G. C., Luyten J. A., van den Heuvel L. P., Keyser A., Gabreëls F. J., Wevers R. A. Two new mutations in the sterol 27-hydroxylase gene in two families lead to cerebrotendinous xanthomatosis. Hum Genet. 1996 Dec;98(6):735–737. doi: 10.1007/s004390050294. [DOI] [PubMed] [Google Scholar]
  25. Watts G. F., Mitchell W. D., Bending J. J., Reshef A., Leitersdorf E. Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherapy. QJM. 1996 Jan;89(1):55–63. doi: 10.1093/oxfordjournals.qjmed.a030138. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES